Screening For BCRL In Targeted Therapy For Breast Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This a prospective, longitudinal study designed to track edema and Breast Cancer Related Lymphedema (BCRL) onset in breast cancer patients taking targeted therapy treatments for early and metastatic breast cancer. A Perometer and Sozo devise will be used to measure volume changes
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjentki w wieku 18-80 lat
- •Z diagnozą raka piersi
- •Co najmniej 4 tygodnie po zabiegu chirurgicznym
- •Leczące się terapią ukierunkowaną na wczesnym lub zaawansowanym stadium choroby
- •Z obrzękiem lub bez obrzęku ramienia
✗ Disqualifies
- •Pacjentki niezdolne do podniesienia ramienia do pozycji pomiaru (90 stopni)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 80 Years
- Last updated (source)
- July 13, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Massachusetts General Hospital
Boston, United States
Trial contact
Alphonse G. Taghian, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/14/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.